Medical device company Flow Neuroscience, creator of the Flow headset and therapy app for depression treatment, today announced it has raised $1.5m in an investment round.
Swedish firm Flow Neuroscience has secured a $1.5m investment – provided to tackle the world’s most urgent mental health challenges with its brain stimulation headset and therapy app.
The technology, called Flow, provides medication-free treatment for conditions such as depression by sending electrical signals to rebalance relevant parts of the brain.
Patients can also use the app to receive health advice from virtual therapists.
The funding is led by Khosla Ventures, a US firm that provides venture assistance and strategic advice to entrepreneurs working on breakthrough technologies.
It will be used to further support its European roll-out and fund clinical studies.
Flow CEO and co-founder Daniel Mansson said: “We’re increasing treatment choice and empowering people to self-manage their symptoms at home with an effective, personalised and non-pharmacological alternative.
“This has the potential to improve the standard of care and reduce global healthcare costs.
“The Khosla Ventures investment will support the next stage of our journey as we cement our position as European leaders of brain stimulation treatment for depression.” – NS Medical Devices